BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36165926)

  • 21. Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.
    Gjyshi O; Flaherty S; Veettil MV; Johnson KE; Chandran B; Bottero V
    J Virol; 2015 Feb; 89(4):2268-86. PubMed ID: 25505069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p62/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death.
    Park JS; Oh SY; Lee DH; Lee YS; Sung SH; Ji HW; Lee MJ; Lee YH; Rhee SG; Bae SH
    Free Radic Res; 2016 Dec; 50(12):1408-1421. PubMed ID: 27780373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation.
    Sun C; Han B; Zhai Y; Zhao H; Li X; Qian J; Hao X; Liu Q; Shen J; Kai G
    Free Radic Biol Med; 2022 Feb; 180():220-235. PubMed ID: 35074488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
    Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
    Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of p-p62 and nuclear Nrf2 in esophageal squamous cell carcinoma and association with radioresistance.
    Wang Z; Zhang J; Li M; Kong L; Yu J
    Thorac Cancer; 2020 Jan; 11(1):130-139. PubMed ID: 31755241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus.
    Fu J; Xiong Z; Huang C; Li J; Yang W; Han Y; Paiboonrungruan C; Major MB; Chen KN; Kang X; Chen X
    J Biol Chem; 2019 Jan; 294(1):327-340. PubMed ID: 30409900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis.
    Xiao S; Liu N; Yang X; Ji G; Li M
    Free Radic Biol Med; 2021 Feb; 164():58-75. PubMed ID: 33307164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequestosome 1 protects esophageal squamous carcinoma cells from apoptosis via stabilizing SKP2 under serum starvation condition.
    Shi C; Pan BQ; Shi F; Xie ZH; Jiang YY; Shang L; Zhang Y; Xu X; Cai Y; Hao JJ; Wang MR
    Oncogene; 2018 Jun; 37(24):3260-3274. PubMed ID: 29551772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The S349T mutation of SQSTM1 links Keap1/Nrf2 signalling to Paget's disease of bone.
    Wright T; Rea SL; Goode A; Bennett AJ; Ratajczak T; Long JE; Searle MS; Goldring CE; Park BK; Copple IM; Layfield R
    Bone; 2013 Feb; 52(2):699-706. PubMed ID: 23117207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MOAP-1-mediated dissociation of p62/SQSTM1 bodies releases Keap1 and suppresses Nrf2 signaling.
    Tan CT; Chang HC; Zhou Q; Yu C; Fu NY; Sabapathy K; Yu VC
    EMBO Rep; 2021 Jan; 22(1):e50854. PubMed ID: 33393215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Target of Oxidative Stress Regulation in Cochleae: Alternative Splicing of the p62/Sqstm1 Gene.
    Li P; Bing D; Wang X; Chen J; Du Z; Sun Y; Qi F; Chu H
    J Mol Neurosci; 2022 Apr; 72(4):830-840. PubMed ID: 35048235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase-separated protein droplets of amyotrophic lateral sclerosis-associated p62/SQSTM1 mutants show reduced inner fluidity.
    Faruk MO; Ichimura Y; Kageyama S; Komatsu-Hirota S; El-Gowily AH; Sou YS; Koike M; Noda NN; Komatsu M
    J Biol Chem; 2021 Dec; 297(6):101405. PubMed ID: 34774801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of the Keap1-mTORC2 axis by cancer-derived Keap1/mLST8 mutations leads to oncogenic mTORC2-AKT activation.
    Chen Y; Jiao D; He H; Sun H; Liu Y; Shi Q; Zhang P; Li Y; Mo R; Gao K; Wang C
    Redox Biol; 2023 Nov; 67():102872. PubMed ID: 37688978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against oxidative stress mediated by the Nrf2/Keap1 axis is impaired in Primary Biliary Cholangitis.
    Wasik U; Milkiewicz M; Kempinska-Podhorodecka A; Milkiewicz P
    Sci Rep; 2017 Mar; 7():44769. PubMed ID: 28333129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phytochemical composition, isolation and hepatoprotective activity of active fraction from Veronica ciliata against acetaminophen-induced acute liver injury via p62-Keap1-Nrf2 signaling pathway.
    Lu Q; Tan S; Gu W; Li F; Hua W; Zhang S; Chen F; Tang L
    J Ethnopharmacol; 2019 Oct; 243():112089. PubMed ID: 31310828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p62-Dependent Phase Separation of Patient-Derived KEAP1 Mutations and NRF2.
    Cloer EW; Siesser PF; Cousins EM; Goldfarb D; Mowrey DD; Harrison JS; Weir SJ; Dokholyan NV; Major MB
    Mol Cell Biol; 2018 Nov; 38(22):. PubMed ID: 30126895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ming-Mu-Di-Huang-Pill Activates SQSTM1 via AMPK-Mediated Autophagic KEAP1 Degradation and Protects RPE Cells from Oxidative Damage.
    Chen X; Zhu Y; Shi X; Zuo J; Hu T; Wu H; Xia Y; Shi W; Wei W
    Oxid Med Cell Longev; 2022; 2022():5851315. PubMed ID: 35378824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Miconazole Contributes to NRF2 Activation by Noncanonical P62-KEAP1 Pathway in Bladder Cancer Cells.
    Tsai TF; Chen PC; Lin YC; Chou KY; Chen HE; Ho CY; Lin JF; Hwang TI
    Drug Des Devel Ther; 2020; 14():1209-1218. PubMed ID: 32273683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymidylate synthase promotes esophageal squamous cell carcinoma growth by relieving oxidative stress through activating nuclear factor erythroid 2-related factor 2 expression.
    Yang J; Zhang J; Chen J; Yang X; Sun H; Zhao Z; Zhou H; Shen H
    PLoS One; 2023; 18(9):e0290264. PubMed ID: 37682862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.
    Yamamoto S; Inoue J; Kawano T; Kozaki K; Omura K; Inazawa J
    Mol Cancer Res; 2014 Jan; 12(1):58-68. PubMed ID: 24307696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.